With the creation of the Somatic Symptom and Related Disorders category of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in 2013, the functional neurological (symptom) disorder diagnostic criteria underwent transformative changes. These included an emphasis on 'rule-in' physical examination signs/semiological features guiding diagnosis and the removal of a required proximal psychological stressor to be linked to symptoms. In addition, the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition somatization disorder, somatoform pain disorder and undifferentiated somatoform disorder conditions were eliminated and collapsed into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic symptom disorder diagnosis. With somatic symptom disorder, emphasis was placed on a cognitive-behavioural (psychological) formulation as the basis for diagnosis in individuals reporting distressing bodily symptoms such as pain and/or fatigue; the need for bodily symptoms to be 'medically unexplained' was removed, and the overall utility of this diagnostic criteria remains debated. A consequence of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition restructuring is that the diagnosis of somatization disorder that encompassed individuals with functional neurological (sensorimotor) symptoms and prominent other bodily symptoms, including pain, was eliminated. This change negatively impacts clinical and research efforts because many patients with functional neurological disorder experience pain, supporting that the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition would benefit from an integrated diagnosis at this intersection. We seek to revisit this with modifications, particularly since pain (and a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition somatization disorder comorbidity, more specifically) is associated with poor clinical prognosis in functional neurological disorder. As a first step, we systematically reviewed the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition somatization disorder literature to detail epidemiologic, healthcare utilization, demographic, diagnostic, medical and psychiatric comorbidity, psychosocial, neurobiological and treatment data. Thereafter, we propose a preliminary revision to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition allowing for the specifier functional neurological disorder 'with prominent pain'. To meet this criterion, core functional neurological symptoms (e.g. limb weakness, gait difficulties, seizures, non-dermatomal sensory loss and/or blindness) would have 'rule-in' signs and pain (>6 months) impairing social and/or occupational functioning would also be present. Two optional secondary specifiers assist in characterizing individuals with cognitive-behavioural (psychological) features recognized to amplify or perpetuate pain and documenting if there is a pain-related comorbidity. The specifier of 'with prominent pain' is etiologically neutral, while secondary specifiers provide additional clarification. We advocate for a similar approach to contextualize fatigue and mixed somatic symptoms in functional neurological disorder. While this preliminary proposal requires prospective data and additional discussion, these revisions offer the potential benefit to readily identify important functional neurological disorder subgroups-resulting in diagnostic, treatment and pathophysiology implications.

Department of Neurology Inselspital University Hospital Bern and Clinical Neurosciences Bern Bern University Switzerland

Department of Psychiatry University Hospital Brno Czech Republic

Functional Neurology Research Group Cognitive Behavioral Neurology Unit Department of Neurology Massachusetts General Hospital Harvard Medical School Boston MA USA

Komentář v

doi: 10.1093/braincomms/fcaa016 PubMed

Komentář v

doi: 10.1093/braincomms/fcaa010 PubMed

Zobrazit více v PubMed

Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM.  Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med  2006; 166: 1512–8. PubMed

Allen LA, Woolfolk RL, Lehrer PM, Gara MA, Escobar JI.  Cognitive behavior therapy for somatization disorder: A preliminary investigation. J Behav Ther Exp Psychiatry  2001; 32: 53–62. PubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn., Text Revision (DSM-IV-TR);  2000.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edn., 2013.

Aybek S, Lidstone SC, Nielsen G, MacGillivray L, Bassetti CL, Lang AE, et al.  What is the role of a specialist assessment clinic for FND? Lessons from three national referral centers. J Neuropsychiatry Clin Neurosci  2020; 32: 79–84. PubMed

Baslet G, Bajestan S, Aybek S, Modirrousta M, Prince J, Cavanna A, et al. Evidence-based practice of the clinical assessment of psychogenic nonepileptic seizures (PNES): a report from the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 2020. PubMed

Battaglia M, Bertella S, Bajo S, Politi E, Bellodi L.  An investigation of the co-occurrence of panic and somatization disorders through temperamental variables. Psychosom Med  1998; 60: 726–9. PubMed

Begue I, Adams C, Stone J, Perez DL.  Structural alterations in functional neurological disorder and related conditions: a software and hardware problem?  NeuroImage Clin  2019; 22: 101798. PubMed PMC

Bleichhardt G, Timmer B, Rief W.  Cognitive-behavioural therapy for patients with multiple somatoform symptoms—a randomised controlled trial in tertiary care. J Psychosom Res  2004; 56: 449–54. PubMed

Briquet P, Traité clinique et therapeutique de l'hystérie. Paris: J.B. Bailliere et fils; 1859.

Brown RC, Berenz EC, Aggen SH, Gardner CO, Knudsen GP, Reichborn-Kjennerud T, et al.  Trauma exposure and Axis I psychopathology: A cotwin control analysis in Norwegian young adults. Psychol Trauma  2014; 6: 652–60. PubMed PMC

Brown RJ, Schrag A, Trimble MR.  Dissociation, childhood interpersonal trauma, and family functioning in patients with somatization disorder. Am J Psychiatry 2005; 162: 899–905. PubMed

Burton C, Fink P, Henningsen P, Lowe B, Rief W, Group E-S.  Functional somatic disorders: discussion paper for a new common classification for research and clinical use. BMC Med  2020; 18: 34. PubMed PMC

Carey PD, Stein DJ, Zungu-Dirwayi N, Seedat S.  Trauma and posttraumatic stress disorder in an urban Xhosa primary care population: prevalence, comorbidity, and service use patterns. J Nerv Ment Dis  2003; 191: 230–6. PubMed

Carson AJ, Stone J, Hansen CH, Duncan R, Cavanagh J, Matthews K, et al.  Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. J Neurol Neurosurg Psychiatry  2015; 86: 295–301. PubMed

Chander KR, Manjunatha N, Binukumar B, Kumar CN, Math SB, Reddy YCJ.  The prevalence and its correlates of somatization disorder at a quaternary mental health centre. Asian J Psychiatry  2019; 42: 24–7. PubMed

Daum C, Hubschmid M, Aybek S.  The value of ‘positive’ clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry  2014; 85: 180–90. PubMed

Davoodi E, Wen A, Dobson KS, Noorbala AA, Mohammadi A, Farahmand Z.  Early maladaptive schemas in depression and somatization disorder. J Affect Disord  2018; 235: 82–9. PubMed

Davoodi E, Wen A, Dobson KS, Noorbala AA, Mohammadi A, Farahmand Z.  Emotion regulation strategies in depression and somatization disorder. Psychol Rep  2019; 122: 2119–36. PubMed

Denk F, McMahon SB, Tracey I.  Pain vulnerability: a neurobiological perspective. Nat Neurosci  2014; 17: 192–200. PubMed

Diez I, Ortiz-Teran L, Williams B, Jalilianhasanpour R, Ospina JP, Dickerson BC, et al.  Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder. J Neurol Neurosurg Psychiatry  2019; 90: 929–38. PubMed PMC

Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, Barsky A, et al.  Somatic symptom disorder: an important change in DSM. J Psychosom Res  2013; 75: 223–8. PubMed

Edwards MJ, Adams RA, Brown H, Parees I, Friston KJ.  A Bayesian account of ‘hysteria’. Brain  2012; 135: 3495–512. PubMed PMC

Epstein SA, Maurer CW, LaFaver K, Ameli R, Sinclair S, Hallett M.  Insights into chronic functional movement disorders: the value of qualitative psychiatric interviews. Psychosomatics  2016; 57: 566–75. PubMed PMC

Escobar JI, Gara M, Waitzkin H, Silver RC, Holman A, Compton W.  DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry  1998; 20: 155–9. PubMed

Espirito-Santo H, Pio-Abreu JL.  Psychiatric symptoms and dissociation in conversion, somatization and dissociative disorders. Aust N Z J Psychiatry  2009; 43: 270–6. PubMed

Fayed N, Andres E, Rojas G, Moreno S, Serrano-Blanco A, Roca M, et al.  Brain dysfunction in fibromyalgia and somatization disorder using proton magnetic resonance spectroscopy: a controlled study. Acta Psychiatr Scand  2012; 126: 115–25. PubMed

Fink P, Hansen MS, Oxhøj ML.  The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res  2004; 56: 413–8. PubMed

Fink P, Hansen MS, Søndergaard L.  Somatoform disorders among first-time referrals to a neurology service. Psychosomatics  2005; 46: 540–8. PubMed

Fjorback LO, Arendt M, Ornbol E, Walach H, Rehfeld E, Schroder A, et al.  Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res  2013; 74: 31–40. PubMed

Frostholm L, Petrie KJ, Ørnbøl E, Fink P.  Are illness perceptions related to future healthcare expenditure in patients with somatoform disorders?  Psychol Med  2014; 44: 2903–11. PubMed

Garcia-Campayo J, Alda M, Sobradiel N, Olivan B, Pascual A.  Personality disorders in somatization disorder patients: a controlled study in Spain. J Psychosom Res  2007; 62: 675–80. PubMed

Garcia Campayo J, Pascual López A, Almárcegui Lafita C, Morales Bara I, Dolz Zaera I, De Vicente Álvarez-Manzaneda E.  P300 endogen evoked potentials in somatization disorder: a controlled study. Actas Esp Psiquiatr  2007; 35: 52–8. PubMed

Garcia-Campayo J, Sanz-Carrillo C, Baringo T, Ceballos C.  SPECT scan in somatization disorder patients: an exploratory study of eleven cases. Aust N Z J Psychiatry  2001; 35: 359–63. PubMed

Gazzola DM, Carlson C, Rugino A, Hirsch S, Starner K, Devinsky O.  Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled study. Epilepsy Behav  2012; 25: 662–5. PubMed

Gelauff JM, Carson A, Ludwig L, Tijssen MAJ, Stone J.  The prognosis of functional limb weakness: a 14-year case-control study. Brain  2019; 142: 2137–48. PubMed

Gelauff JM, Rosmalen JGM, Gardien J, Stone J, Tijssen MAJ.  Shared demographics and comorbidities in different functional motor disorders. Parkinsonism Relat Disord  2020; 70: 1–6. PubMed

Glass SP, Matin N, Williams B, Mello J, Stephen CD, Young SS, et al.  Neuropsychiatric factors linked to adherence and short-term outcome in a U.S. functional neurological disorders clinic: a retrospective cohort study. J Neuropsychiatry Clin Neurosci 2018; 30: 152–9. PubMed

Guo W, Liu F, Chen J, Wu R, Li L, Zhang Z, et al.  Anatomical distance affects cortical–subcortical connectivity in first-episode, drug-naive somatization disorder. J Affect Disord  2017; 217: 153–8. PubMed

Guz H, Doganay Z, Ozkan A, Colak E, Tomac A, Sarisoy G.  Conversion and somatization disorders: dissociative symptoms and other characteristics. J Psychosom Res  2004; 56: 287–91. PubMed

Hiller W, Fichter MM, Rief W.  A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res  2003; 54: 369–80. PubMed

Hiller W, Heuser J, Fichter MM.  The DSM-IV nosology of chronic pain: a comparison of pain disorder and multiple somatization syndrome. Eur J Pain  2000; 4: 45–55. PubMed

Hossain I, Islam SN, Khan Md NI, Islam S, Hasnat A.  Serum level of copper, zinc and manganese in somatization disorder patients. German J Psychiatry  2007. a; 10: 41–5.

Hossain I, Sadat N, Hossain K, Qusar S, Islam SN, Islam S, et al.  Serum immunoglobulin profile in somatization disorder patients. German J Psychiatry  2007. b; 10: 13–7.

Ibrahim NM, Martino D, van de Warrenburg BP, Quinn NP, Bhatia KP, Brown RJ, et al.  The prognosis of fixed dystonia: a follow-up study. Parkinsonism Relat Disord  2009; 15: 592–7. PubMed

Interian A, Gara MA, Diaz-Martinez AM, Warman MJ, Escobar JI, Allen LA, et al.  The value of pseudoneurological symptoms for assessing psychopathology in primary care. Psychosom Med  2004; 66: 141–6. PubMed

Jimenez XF, Aboussouan A, Johnson J.  Functional neurological disorder responds favorably to interdisciplinary rehabilitation models. Psychosomatics  2019; 60: 556–62. PubMed

Kırpınar I, Deveci E, Kılıç A, Camur D.  Somatization disorder and hypochondriasis: as like as two peas?  Anadolu Psikiyatri Derg  2016; 17: 165.

Kozlowska K, Nunn KP, Rose D, Morris A, Ouvrier RA, Varghese J.  Conversion disorder in Australian pediatric practice. J Am Acad Child Adolesc Psychiatry  2007; 46: 68–75. PubMed

Kuwabara H, Otsuka M, Shindo M, Ono S, Shioiri T, Someya T.  Diagnostic classification and demographic features in 283 patients with somatoform disorder. Psychiatry Clin Neurosci  2007; 61: 283–9. PubMed

Landa A, Bossis AP, Boylan LS, Wong PS.  Beyond the unexplainable pain: relational world of patients with somatization syndromes. J Nerv Ment Dis  2012; 200: 413–22. PubMed

Lehmann M, Jonas C, Pohontsch NJ, Zimmermann T, Scherer M, Lowe B.  General practitioners' views on the diagnostic innovations in DSM-5 somatic symptom disorder—a focus group study. J Psychosom Res  2019; 123: 109734. PubMed

Li R, Liu F, Su Q, Zhang Z, Zhao J, Wang Y, et al.  Bidirectional causal connectivity in the cortico-limbic-cerebellar circuit related to structural alterations in first-episode, drug-naive somatization disorder. Front Psychiatry  2018; 9. PubMed PMC

Ludwig L, Pasman JA, Nicholson T, Aybek S, David AS, Tuck S, et al.  Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry  2018; 5: 307–20. PubMed

Lynch DJ, McGrady A, Nagel R, Zsembik C.  Somatization in family practice: comparing 5 methods of classification. Prim Care Companion J Clin Psychiatry  1999; 1: 85–9. PubMed PMC

Mai FM, Merskey H.  Briquet's Treatise on hysteria. A synopsis and commentary. Arch Gen Psychiatry  1980; 37: 1401–5. PubMed

Mai FM, Merskey H.  Briquet's concept of hysteria: an historical perspective. Can J Psychiatry  1981; 26: 57–63. PubMed

Manchikanti L, Cash KA, Pampati V, Fellows B.  Influence of psychological variables on the diagnosis of facet joint involvement in chronic spinal pain. Pain Physician  2008; 11: 145–60. PubMed

Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V.  Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag  2007; 3: 89–100. PubMed

Marchetti RL, Kurcgant D, Neto JG, von Bismark MA, Marchetti LB, Fiore LA.  Psychiatric diagnoses of patients with psychogenic non-epileptic seizures. Seizure  2008; 17: 247–53. PubMed

Martin A, Rauh E, Fichter M, Rief W.  A one-session treatment for patients suffering from medically unexplained symptoms in primary care: a randomized clinical trial. Psychosomatics  2007; 48: 294–303. PubMed

Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M.  Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005; 162: 847–55. PubMed

Miller AR, North CS, Clouse RE, Wetzel RD, Spitznagel EL, Alpers DH.  The association of irritable bowel syndrome and somatization disorder. Ann of Clin Psychiatry  2001; 13: 25–30. PubMed

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med  2009; 6: e1000097. PubMed PMC

Mohlman J, de Jesus M, Gorenstein EE, Kleber M, Gorman JM, Papp LA.  Distinguishing generalized anxiety disorder, panic disorder, and mixed anxiety states in older treatment-seeking adults. J Anxiety Disord  2004; 18: 275–90. PubMed

Morse DS, Suchman AL, Frankel RM.  The meaning of symptoms in 10 women with somatization disorder and a history of childhood abuse. Arch Fam Med  1997; 6: 468–76. PubMed

Myers L, Lancman M, Laban-Grant O, Matzner B, Lancman M.  Psychogenic non-epileptic seizures: predisposing factors to diminished quality of life. Epilepsy Behav  2012; 25: 358–62. PubMed

Nielsen G, Buszewicz M, Stevenson F, Hunter R, Holt K, Dudziec M, et al.  Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry  2017; 88: 484–90. PubMed

NIH: National Heart Lung and Blood Institute. Study quality assessment tools. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools

North CS, Downs D, Clouse RE, Alrakawi A, Dokucu ME, Cox J, et al.  The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol  2004; 2: 787–95. PubMed

Ou Y, Liu F, Chen J, Pan P, Wu R, Su Q, et al.  Increased coherence-based regional homogeneity in resting-state patients with first-episode, drug-naive somatization disorder. J Affect Disord  2018; 235: 150–4. PubMed

Ozturk E, Sar V.  Somatization as a predictor of suicidal ideation in dissociative disorders. Psychiatry Clin Neurosci  2008; 62: 662–8. PubMed

Padhy SK, Mishra S, Sarkar S, Bang LG, Panigrahi M.  Comparison of psychiatric morbidity in patients with irritable bowel syndrome and non-ulcer dyspepsia. Ind Psychiatry J  2016; 25: 29–34. PubMed PMC

Pan P, Ou Y, Su Q, Liu F, Chen J, Zhao J, et al.  Voxel-based global-brain functional connectivity alterations in first-episode drug-naive patients with somatization disorder. J Affect Disord  2019; 254: 82–9. PubMed

Perez DL, Aybek S, Popkirov S, Kozlowska K, Stephen CD, Anderson J, et al. A review and expert opinion on the neuropsychiatric assessment of motor functional neurological disorders. J Neuropsychiatry Clin Neurosci 2020. PubMed

Perley MJ, Guze SB.  Hysteria—the stability and usefulness of clinical criteria. A quantitative study based on a follow-up period of six to eight years in 39 patients. N Engl J Med  1962; 266: 421–6. PubMed

Pick S, Goldstein LH, Perez DL, Nicholson TR.  Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda. J Neurol Neurosurg Psychiatry  2019; 90: 704–11. PubMed PMC

Popkirov S, Hoeritzauer I, Colvin L, Carson AJ, Stone J.  Complex regional pain syndrome and functional neurological disorders—time for reconciliation. J Neurol Neurosurg Psychiatry  2019; 90: 608–14. PubMed

Prerana G, Jigar H, Singh S, Shweta C, Singh S, Ibrahim A, et al.  Somatization disorder: are we moving towards an over-generalized and overinclusive diagnosis in DSM-V?  Acta Med Int  2017; 4: 110–19.

Rief W, Hiller W.  A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics  2003; 44: 492–8. PubMed

Rief W, Mewes R, Martin A, Glaesmer H, Brähler E.  Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosom Med  2011; 73: 760–8. PubMed

Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M.  Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res  2001; 105: 165–74. PubMed

Sanyal S, Chattopadhyay PK, Biswas D.  Electro-dermal arousal and self-appraisal in patients with somatization disorder. Indian J Clin Psychology  1998; 25: 144–8.

Scamvougeras A, Howard A.  Somatic symptom disorder, medically unexplained symptoms, somatoform disorders, functional neurological disorder: how DSM-5 got it wrong. Can J Psychiatry  2020; 65: 301–5. PubMed PMC

Schrag A, Trimble M, Quinn N, Bhatia K.  The syndrome of fixed dystonia: an evaluation of 103 patients. Brain  2004; 127: 2360–72. PubMed

Schröder A, Heider J, Zaby A, Göllner R.  Cognitive Behavioral therapy versus progressive muscle relaxation training for multiple somatoform symptoms: results of a randomized controlled trial. Cogn Ther Res  2013; 37: 296–306.

Schröder A, Rehfeld E, Ornbøl E, Sharpe M, Licht RW, Fink P.  Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br J Psychiatry  2012; 200: 499–507. PubMed

Sertoz OO, Doganavsargil O, Elbi H.  Body image and self-esteem in somatizing patients. Psychiatry Clin Neurosci  2009; 63: 508–15. PubMed

Simon GE, Gureje O.  Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry  1999; 56: 90–5. PubMed

Smith RC, Gardiner JC, Lyles JS, Sirbu C, Dwamena FC, Hodges A, et al.  Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med  2005; 67: 123–9. PubMed PMC

Song Y, Su Q, Jiang M, Liu F, Yao D, Dai Y, et al.  Abnormal regional homogeneity and its correlations with personality in first-episode, treatment-naive somatization disorder. Int J Psychophysiol  2015; 97: 108–12. PubMed

Spitzer C, Barnow S, Gau K, Freyberger HJ, Grabe HJ.  Childhood maltreatment in patients with somatization disorder. Aust N Z J Psychiatry  2008; 42: 335–41. PubMed

Spitzer C, Barnow S, Wingenfeld K, Rose M, Lowe B, Grabe HJ.  Complex post-traumatic stress disorder in patients with somatization disorder. Aust N Z J Psychiatry  2009; 43: 80–6. PubMed

Stone J, LaFrance WC, Jr, Levenson JL, Sharpe M.  Issues for DSM-5: conversion disorder. Am J Psychiatry 2010. a; 167: 626–7. PubMed

Stone J, Warlow C, Sharpe M.  The symptom of functional weakness: a controlled study of 107 patients. Brain  2010. b; 133: 1537–51. PubMed

Su Q, Yao D, Jiang M, Liu F, Jiang J, Xu C, et al.  Dissociation of regional activity in default mode network in medication-naive, first-episode somatization disorder. PLoS One  2014; 9: e99273. PubMed PMC

Su Q, Yao D, Jiang M, Liu F, Jiang J, Xu C, et al.  Increased functional connectivity strength of right inferior temporal gyrus in first-episode, drug-naive somatization disorder. Aust N Z J Psychiatry  2015; 49: 74–81. PubMed

Su Q, Yao D, Jiang M, Liu F, Long L, Dai Y, et al.  Decreased interhemispheric functional connectivity in insula and angular gyrus/supramarginal gyrus: significant findings in first-episode, drug-naive somatization disorder. Psychiatry Res  2016; 248: 48–54. PubMed

Taycan O, Sar V, Celik C, Erdogan-Taycan S.  Trauma-related psychiatric comorbidity of somatization disorder among women in eastern Turkey. Compr Psychiatry  2014; 55: 1837–46. PubMed

van der Feltz-Cornelis CM, Elfeddali I, Werneke U, Malt UF, Van den Bergh O, Schaefert R, et al.  A European research agenda for somatic symptom disorders, bodily distress disorders, and functional disorders: results of an estimate-talk-estimate Delphi expert study. Front Psychiatry  2018; 9. PubMed PMC

van Ravesteijn H, Lucassen P, Bor H, van Weel C, Speckens A.  Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: a randomized controlled trial. Psychother Psychosom  2013; 82: 299–310. PubMed

Věchetová G, Slovák M, Kemlink D, Hanzlíková Z, Dušek P, Nikolai T, et al.  The impact of non-motor symptoms on the health-related quality of life in patients with functional movement disorders. J Psychosom Res  2018; 115: 32–7. PubMed

Voon V, Lang AE.  Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry  2005; 66: 1529–34. PubMed

Wang H, Guo W, Liu F, Chen J, Wu R, Zhang Z, et al.  Clinical significance of increased cerebellar default-mode network connectivity in resting-state patients with drug-naive somatization disorder. Medicine (Baltimore)  2016; 95: e4043. PubMed PMC

Wei S, Su Q, Jiang M, Liu F, Yao D, Dai Y, et al.  Abnormal default-mode network homogeneity and its correlations with personality in drug-naive somatization disorder at rest. J Affect Disord  2016; 193: 81–8. PubMed

Weiss FD, Rief W, Kleinstauber M.  Health care utilization in outpatients with somatoform disorders: descriptives, interdiagnostic differences, and potential mediating factors. Gen Hosp Psychiatry  2017; 44: 22–9. PubMed

Zonneveld LN, van Rood YR, Timman R, Kooiman CG, Van't Spijker A, Busschbach JJ.  Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. PLoS One  2012; 7: e42629. PubMed PMC

Are Functional (Psychogenic Nonepileptic) Seizures the Sole Expression of Psychological Processes?

Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda